[Histonet] need cd19 help in mouse spleens and a job

Tarango, Mark mtarango <@t> nvcancer.org
Mon Nov 26 12:35:49 CST 2007

BioCare recently came out with an anti-CD19 antibody that works in FFPE
tissue sections.

Mark Adam Tarango HT(ASCP)
Histology & IHC Supervisor
Nevada Cancer Institute
One Breakthrough Way
Las Vegas, NV  89135
Direct Line (702) 822-5112
Treo (702) 759-9229
Fax (702) 939-7663

-----Original Message-----
From: histonet-bounces <@t> lists.utsouthwestern.edu
[mailto:histonet-bounces <@t> lists.utsouthwestern.edu] On Behalf Of Madary,
Sent: Monday, November 26, 2007 8:49 AM
To: histonet <@t> lists.utsouthwestern.edu
Subject: [Histonet] need cd19 help in mouse spleens and a job

I need help finding a source and even a decent procedure that works on
cd19 on FFPE mouse spleens.  I have a decent procedure for cd3 and cd45,
but the path wants cd19, so I figured I would throw it to the experts
first.  Thanks in advance.  Also Medimmune is looking for a histotech
here in Rockville Md.  Someone with GLP, frozen and IHC experience.



Histology Mgr, Medimmune

301.398.6360(lab), 4745(vm),9745(fax)


"To the extent this electronic communication or any of its attachments
contain information that is not in the public domain, such information
is considered by MedImmune to be confidential and proprietary, and
expected to be used only by the individual(s) for whom it is intended.
If you have received this electronic communication in error, please
reply to the sender advising of the error in transmission and delete the
original message and any accompanying documents from your system
immediately, without copying, reviewing or otherwise using them for any
purpose.  Thank you for your cooperation."



Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu

"EMF <nvcancer.org>" made the following annotations.
CONFIDENTIALITY NOTICE: This e-mail message, including any
attachments, is for the sole use of the intended 
recipient(s) and may contain confidential, proprietary, 
and/or privileged information protected by law. If you are 
not the intended recipient, you may not use, copy, or 
distribute this e-mail message or its attachments. If you 
believe you have received this e-mail message in error, 
please contact the sender by reply e-mail and destroy all 
copies of the original message

More information about the Histonet mailing list